Client 1ST Advisory Group LLC Invests $292,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Client 1ST Advisory Group LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 578 shares of the healthcare conglomerate’s stock, valued at approximately $292,000.

Several other hedge funds also recently made changes to their positions in UNH. Brady Martz Wealth Solutions LLC acquired a new position in UnitedHealth Group in the fourth quarter worth approximately $978,000. Delta Capital Management LLC grew its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Delta Capital Management LLC now owns 7,250 shares of the healthcare conglomerate’s stock worth $3,667,000 after acquiring an additional 60 shares during the last quarter. My Legacy Advisors LLC lifted its holdings in shares of UnitedHealth Group by 1.6% during the fourth quarter. My Legacy Advisors LLC now owns 4,812 shares of the healthcare conglomerate’s stock valued at $2,615,000 after purchasing an additional 78 shares during the last quarter. Arbor Trust Wealth Advisors LLC increased its stake in UnitedHealth Group by 11.2% in the 4th quarter. Arbor Trust Wealth Advisors LLC now owns 3,017 shares of the healthcare conglomerate’s stock worth $1,526,000 after purchasing an additional 304 shares in the last quarter. Finally, Liberty One Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 7.2% in the fourth quarter. Liberty One Investment Management LLC now owns 8,248 shares of the healthcare conglomerate’s stock worth $4,172,000 after buying an additional 551 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on UNH shares. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Stock Performance

Shares of UNH opened at $510.03 on Monday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company’s fifty day moving average price is $549.37 and its 200 day moving average price is $563.18. The company has a market capitalization of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business posted $5.83 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.